The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback